CoChat

Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples

Open access

Published version of a preprint

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

To explore the potential modes of Severe Acute Respiratory Coronavirus-2 (SARS-CoV-2) transmission, we collected 535 diverse clinical and environmental samples from 75 infected hospitalized and community patients. Infectious SARS-CoV-2 with quantitative burdens varying from 5 plaque-forming units/mL (PFU/mL) up to 1.0 × 10 6 PFU/mL was detected in 151/459 (33%) of the specimens assayed and up to 1.3 × 10 6 PFU/mL on fomites with confirmation by plaque morphology, PCR, immunohistochemistry, and/or sequencing. Infectious virus in clinical and associated environmental samples correlated with time since symptom onset with no detection after 7–8 days in immunocompetent hosts and with N-gene based C t values ≤ 25 significantly predictive of yielding plaques in culture. SARS-CoV-2 isolated from patient respiratory tract samples caused illness in a hamster model with a minimum infectious dose of ≤ 14 PFU. Together, our findings offer compelling evidence that large respiratory droplet and contact (direct and indirect i.e., fomites) are important modes of SARS-CoV-2 transmission.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-022-09218-5

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 SARS-CoV-2 plaque morphology. (a–c) Variation in plaque sizes when clinical samples are plated on Vero CCL-81 cells. Note the characteristic halo structure. (d) SARS-CoV-2 plaques on Vero E6/TMPRSS2 cells. (e–f) SARS-CoV-2 plaques on CCL-81 cells stained with crystal violet (e) and immunohistochemical staining with an anti-SARS-CoV-2 spike antibody (f). (g–i) SARS-CoV-2 variants of concern on Vero CCL81 cells (g: Alpha; h: Beta; i: Gamma). j Patient samples passed through 0.2 mm filters to remove bacterial and fungal contamination. Top row: unfiltered samples; Bottom row: filtered samples. Arrows show examples of false plaques caused by growth of bacteria/fungi on the cell monolayers. Figure prepared using Photoshop v23.0 (https://www.adobe.com).
Figure 1 SARS-CoV-2 plaque morphology. (a–c) Variation in plaque sizes when clinical samples are plated on Vero CCL-81 cells. Note the characteristic halo structure. (d) SARS-CoV-2 plaques on Vero E6/TMPRSS2 cells. (e–f) SARS-CoV-2 plaques on CCL-81 cells stained with crystal violet (e) and immunohistochemical staining with an anti-SARS-CoV-2 spike antibody (f). (g–i) SARS-CoV-2 variants of concern on Vero CCL81 cells (g: Alpha; h: Beta; i: Gamma). j Patient samples passed through 0.2 mm filters to remove bacterial and fungal contamination. Top row: unfiltered samples; Bottom row: filtered samples. Arrows show examples of false plaques caused by growth of bacteria/fungi on the cell monolayers. Figure prepared using Photoshop v23.0 (https://www.adobe.com).CC BY · PubMed Central
Figure 2 SARS-CoV-2 detection using PCR and plaque assays. (a) Comparison of reverse transcriptase qPCR assays. At the mid-point of the plot, the N gene-based assay generates Ct values that are about two values lower that Ct measured using E or RDRP gene primers. The solid lines were calculated from a linear regression (y = 0.84x + 5.9, goodness of fit r2 = 0.67; y = 0.68 + 11.6, goodness of fit r2 = 0.59) for E and RdRP assays, respectively. (b) Relationships between N gene-based Ct values and virus titer measured as plaque forming units (PFU). The samples exhibited a wide range of virus titers varying from > 106 PFU/mL to the limit of detection (~ 5 PFU/mL). A linear regression fitted to the log10-transformed data is also shown (y = − 0.16x + 5.9; r2 = 0.41) along with the 95% confidence intervals. Specimens bearing no detectable infectious SARS-CoV-2 virus are also plotted for purposes of comparison (black squares). Most of the specimens (97%) were titered on Vero CCL-81 cells. Figure prepared using Prism v9.3 (https://www.graphpad.com).
Figure 2 SARS-CoV-2 detection using PCR and plaque assays. (a) Comparison of reverse transcriptase qPCR assays. At the mid-point of the plot, the N gene-based assay generates Ct values that are about two values lower that Ct measured using E or RDRP gene primers. The solid lines were calculated from a linear regression (y = 0.84x + 5.9, goodness of fit r2 = 0.67; y = 0.68 + 11.6, goodness of fit r2 = 0.59) for E and RdRP assays, respectively. (b) Relationships between N gene-based Ct values and virus titer measured as plaque forming units (PFU). The samples exhibited a wide range of virus titers varying from > 106 PFU/mL to the limit of detection (~ 5 PFU/mL). A linear regression fitted to the log10-transformed data is also shown (y = − 0.16x + 5.9; r2 = 0.41) along with the 95% confidence intervals. Specimens bearing no detectable infectious SARS-CoV-2 virus are also plotted for purposes of comparison (black squares). Most of the specimens (97%) were titered on Vero CCL-81 cells. Figure prepared using Prism v9.3 (https://www.graphpad.com).CC BY · PubMed Central
Figure 3 Impact of sample timing on SARS-CoV-2 virus detection. The time post-onset was calculated from interviews and/or chart review. (a) Virus titer where it could be detected. (b) All the Ct measurements acquired over the study. In most cases, the capacity to detect virus drops off precipitously about a week after case onset (blue data points). However, both RNA (lower panel) and PFU (upper panel) are detected for many days or weeks later where the patient is immunocompromised (red data points). Figure prepared using Prism v9.3 (https://www.graphpad.com).
Figure 3 Impact of sample timing on SARS-CoV-2 virus detection. The time post-onset was calculated from interviews and/or chart review. (a) Virus titer where it could be detected. (b) All the Ct measurements acquired over the study. In most cases, the capacity to detect virus drops off precipitously about a week after case onset (blue data points). However, both RNA (lower panel) and PFU (upper panel) are detected for many days or weeks later where the patient is immunocompromised (red data points). Figure prepared using Prism v9.3 (https://www.graphpad.com).CC BY · PubMed Central
Figure 4 Percentage of clinical and environmental samples positive for infectious SARS-CoV-2 from patients with positive NP or TS by infectious titer. The number of samples acquired in each category are indicated above each bar, along with the minimum and maximum infectious titer (PFU/mL) observed for each sample along the top of the figure. Not all sample types were collected from every patient. Sputum indicates productive cough samples. ND = None detected. Figure prepared using Prism v9.3 (https://www.graphpad.com).
Figure 4 Percentage of clinical and environmental samples positive for infectious SARS-CoV-2 from patients with positive NP or TS by infectious titer. The number of samples acquired in each category are indicated above each bar, along with the minimum and maximum infectious titer (PFU/mL) observed for each sample along the top of the figure. Not all sample types were collected from every patient. Sputum indicates productive cough samples. ND = None detected. Figure prepared using Prism v9.3 (https://www.graphpad.com).CC BY · PubMed Central
Figure 5 Stability of SARS-CoV-2. (a) Saliva from a COVID-19 patient, or saliva mixed with DMEM + serum, were left in open Petri dishes in a patient care room. Image showing the effects of leaving a saliva sample (dish 1), or saliva mixed with DMEM + serum (dish 2) for 2 h. The saliva specimen dried completely. (b) Effect of standing time and drying on virus titers. The two control samples (blue bars) were stored on ice in closed tubes during the two-hour experiment. (c) Representative patient-contacted surfaces were acquired from the patient care setting and transferred for testing without further treatment beyond everyday maintenance and cleaning. Some were partly disassembled to facilitate safe handling and access. An endotracheal tube sample, containing 1 × 106 PFU/mL SARS-CoV-2 diluted in DMEM, was applied in three 10 µL volumes to each item and either retrieved immediately, or stored in a biocontainment hood for the indicated times before recovery and plaque assay. The figure shows a linear regression applied to the log10-transformed plaque counts. The half-lives were separately calculated from a non-linear fit to the untransformed data (not shown) and ranged from 3 min (digital device cover) to 82 min (keyboard). Figure assembled using Illustrator v26.0 (https://www.adobe.com) and Prism v9.3 (https://www.graphpad.com).
Figure 5 Stability of SARS-CoV-2. (a) Saliva from a COVID-19 patient, or saliva mixed with DMEM + serum, were left in open Petri dishes in a patient care room. Image showing the effects of leaving a saliva sample (dish 1), or saliva mixed with DMEM + serum (dish 2) for 2 h. The saliva specimen dried completely. (b) Effect of standing time and drying on virus titers. The two control samples (blue bars) were stored on ice in closed tubes during the two-hour experiment. (c) Representative patient-contacted surfaces were acquired from the patient care setting and transferred for testing without further treatment beyond everyday maintenance and cleaning. Some were partly disassembled to facilitate safe handling and access. An endotracheal tube sample, containing 1 × 106 PFU/mL SARS-CoV-2 diluted in DMEM, was applied in three 10 µL volumes to each item and either retrieved immediately, or stored in a biocontainment hood for the indicated times before recovery and plaque assay. The figure shows a linear regression applied to the log10-transformed plaque counts. The half-lives were separately calculated from a non-linear fit to the untransformed data (not shown) and ranged from 3 min (digital device cover) to 82 min (keyboard). Figure assembled using Illustrator v26.0 (https://www.adobe.com) and Prism v9.3 (https://www.graphpad.com).CC BY · PubMed Central
Figure 6 Infectious SARS-CoV-2 in saliva, sputum, and cough specimens. (a) Virus samples were acquired from NP swabs as well as cough bag samples (CB), sputum (SP), or saliva (S). Samples determined to contain infectious virus are indicated with solid-colour coding. (b) Virus samples were acquired from NP swabs as well as saliva. A Ct ≤ 25 in the NP swab predicts that about 1/3–1/2 of the cough/sputum and saliva specimens will also bear infectious virus, respectively. Figure prepared using Prism v9.3 (https://www.graphpad.com).
Figure 6 Infectious SARS-CoV-2 in saliva, sputum, and cough specimens. (a) Virus samples were acquired from NP swabs as well as cough bag samples (CB), sputum (SP), or saliva (S). Samples determined to contain infectious virus are indicated with solid-colour coding. (b) Virus samples were acquired from NP swabs as well as saliva. A Ct ≤ 25 in the NP swab predicts that about 1/3–1/2 of the cough/sputum and saliva specimens will also bear infectious virus, respectively. Figure prepared using Prism v9.3 (https://www.graphpad.com).CC BY · PubMed Central
Figure 7 Relationship between Ct and positive plaque assays. The specimens were divided into plaque-positive, and plaque-negative categories and the distribution of Ct values calculated using bin steps of two. A non-linear fit of two Gaussian curves to these data is also shown. A sample with a Ct ≤ 25 is 84% likely to bear infectious material while samples with Ct > 25 are 88% negative. An unpaired t-test, using Welch’s correction for unequal variances and sample sizes, indicates that the two means (19.6 ± 5.1 SD versus 29.2 ± 4.2 SD) are significantly different (two-tailed P < 0.0001). Red or blue filled shading indicates that the binning process counted no specimens in these bins. Figure prepared using Prism v9.3 (https://www.graphpad.com).
Figure 7 Relationship between Ct and positive plaque assays. The specimens were divided into plaque-positive, and plaque-negative categories and the distribution of Ct values calculated using bin steps of two. A non-linear fit of two Gaussian curves to these data is also shown. A sample with a Ct ≤ 25 is 84% likely to bear infectious material while samples with Ct > 25 are 88% negative. An unpaired t-test, using Welch’s correction for unequal variances and sample sizes, indicates that the two means (19.6 ± 5.1 SD versus 29.2 ± 4.2 SD) are significantly different (two-tailed P < 0.0001). Red or blue filled shading indicates that the binning process counted no specimens in these bins. Figure prepared using Prism v9.3 (https://www.graphpad.com).CC BY · PubMed Central
Figure 8 Relationship between viral RNA quantity, PFU, and sample timing. (a) The ratio of RNA to PFU was calculated using the virus titer plus a determination of the number of N-gene copies across all of the specimens. The ratios were log10 transformed and the distribution calculated across bin steps of one log10. A non-linear fit of a Gaussian curve to these data is also shown, centered on a mean of 5.2 ± 1.0 SD. This represents 105.2 = 160,000 RNA copies per PFU. (b) The total quantity of virus in each infectious specimen was calculated using the titer (PFU/mL) and the known collection volumes (i.e., specimen + carrier/diluent). These values were then averaged across all of the samples for each of the indicated days. The plot shows a linear regression fitted to the log10-transformed data along with the 95% confidence intervals (y = − 0.14x + 4.0, goodness of fit r2 = 0.05). The negative slope is significantly non-zero (P = 0.015, F-test). Error bars represent standard deviation. The average virus load declined about tenfold over the course of a week beginning at ~ 104.0 PFU/mL on a hypothetical day zero. (c) The relative infectivity was calculated using the virus titer (PFU/mL) and specific quantity of virus RNA/mL in each sample. The plot shows a linear regression fitted to the log10-transformed data along with the 95% confidence intervals (y = 0.12x + 4.9; goodness of fit r2 = 0.04). The positive slope is significantly non-zero (P = 0.032, F-test). Error bars represent standard deviation. The ratio of RNA/PFU increased about eightfold over the same seven days, starting at ~ 104.9 RNA/PFU on day zero. Figure prepared using Prism v9.3 (https://www.graphpad.com).
Figure 8 Relationship between viral RNA quantity, PFU, and sample timing. (a) The ratio of RNA to PFU was calculated using the virus titer plus a determination of the number of N-gene copies across all of the specimens. The ratios were log10 transformed and the distribution calculated across bin steps of one log10. A non-linear fit of a Gaussian curve to these data is also shown, centered on a mean of 5.2 ± 1.0 SD. This represents 105.2 = 160,000 RNA copies per PFU. (b) The total quantity of virus in each infectious specimen was calculated using the titer (PFU/mL) and the known collection volumes (i.e., specimen + carrier/diluent). These values were then averaged across all of the samples for each of the indicated days. The plot shows a linear regression fitted to the log10-transformed data along with the 95% confidence intervals (y = − 0.14x + 4.0, goodness of fit r2 = 0.05). The negative slope is significantly non-zero (P = 0.015, F-test). Error bars represent standard deviation. The average virus load declined about tenfold over the course of a week beginning at ~ 104.0 PFU/mL on a hypothetical day zero. (c) The relative infectivity was calculated using the virus titer (PFU/mL) and specific quantity of virus RNA/mL in each sample. The plot shows a linear regression fitted to the log10-transformed data along with the 95% confidence intervals (y = 0.12x + 4.9; goodness of fit r2 = 0.04). The positive slope is significantly non-zero (P = 0.032, F-test). Error bars represent standard deviation. The ratio of RNA/PFU increased about eightfold over the same seven days, starting at ~ 104.9 RNA/PFU on day zero. Figure prepared using Prism v9.3 (https://www.graphpad.com).CC BY · PubMed Central
Figure 9 Virulence testing in Syrian hamsters. Two of the virus specimens (56B and 72B) were plaque purified and expanded to higher titers with one passage. The two stocks were then used to inoculate four groups of hamsters (4 per group) with the indicated doses of virus. Four control animals were also inoculated by the same intranasal route, with an equal volume (100 µL total) of serum-free media. (a) Shows the weight change relative to the starting weight for the animals in each of the five groups. Error bars represent standard error of the mean. A nasal swab was collected from each animal on days 1, 3 and 6, post-inoculation, and assayed for virus by plaque assay and virus RNA by qPCR (b and c). Both virus specimens produced weight loss and high titers of intranasal virus were detected at days 1 and 3 post-infection. Characteristically the lower doses (14 PFU for 56B and 30 PFU for 72B) yielded the most virus on day 3 post-infection, whereas the higher doses induced the highest levels of infection immediately after challenge, on day 1. The RNA is more persistent than virus, and it could still be detected 6 days post-infection in all of the infected animals, whereas no virus could be detected at this date. The animals were euthanized at day 14. The dashed lines show the limits of virus and RNA detection (LOD) in nasal swabs. Figure prepared using Prism v9.3 (https://www.graphpad.com).
Figure 9 Virulence testing in Syrian hamsters. Two of the virus specimens (56B and 72B) were plaque purified and expanded to higher titers with one passage. The two stocks were then used to inoculate four groups of hamsters (4 per group) with the indicated doses of virus. Four control animals were also inoculated by the same intranasal route, with an equal volume (100 µL total) of serum-free media. (a) Shows the weight change relative to the starting weight for the animals in each of the five groups. Error bars represent standard error of the mean. A nasal swab was collected from each animal on days 1, 3 and 6, post-inoculation, and assayed for virus by plaque assay and virus RNA by qPCR (b and c). Both virus specimens produced weight loss and high titers of intranasal virus were detected at days 1 and 3 post-infection. Characteristically the lower doses (14 PFU for 56B and 30 PFU for 72B) yielded the most virus on day 3 post-infection, whereas the higher doses induced the highest levels of infection immediately after challenge, on day 1. The RNA is more persistent than virus, and it could still be detected 6 days post-infection in all of the infected animals, whereas no virus could be detected at this date. The animals were euthanized at day 14. The dashed lines show the limits of virus and RNA detection (LOD) in nasal swabs. Figure prepared using Prism v9.3 (https://www.graphpad.com).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 74

Metadata

Authors
Lin, Y.-C., Malott, R. J., Ward, L., Kiplagat, L., Pabbaraju, K., Gill, K., Berenger, B. M., Hu, J., Fonseca, K., Noyce, R. S., Louie, T., Evans, D. H., & Conly, J. M.
Affiliations
  • University of Alberta (CA)
  • University of Calgary (CA)
  • Alberta Health Services (CA)
  • Alberta Precision Laboratories (CA)
Corresponding author
Evans, David H.
Venue
Scientific Reports
Published
2022-03-30
Volume
12
Issue
1
Pages
5418-5418
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4220727626
Cited by
74
References
57
Citations by year
2026: 2 · 2025: 10 · 2024: 18 · 2023: 21 · 2022: 20
FWCI
8.43
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • medRxiv (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Canadian Institutes for Health Research
  • University of Alberta’s Li Ka Shing Institute of Virology
  • University of Calgary COVID-19 Research Fund
  • Alberta Health Services, Alberta Precision Laboratories Internal Operating Funds
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, SARS-CoV-2 transmission, fomites, environmental contamination, respiratory droplets, contact transmission, plaque-forming units, hamster model, minimum infectious dose, hospitalized patients, community patients, viral shedding
MeSH terms
COVID-19, SARS-CoV-2, Humans, Respiratory System, Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples. https://app.cochat.ai/papers/10.1038/s41598-022-09218-5
The paper
Lin, Y.-C., Malott, R. J., Ward, L., Kiplagat, L., Pabbaraju, K., Gill, K., Berenger, B. M., Hu, J., Fonseca, K., Noyce, R. S., Louie, T., Evans, D. H., & Conly, J. M. (2022). Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples. Scientific Reports. https://doi.org/10.1038/s41598-022-09218-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.